3,4-methylenedioxy-N-ethylamphetamine
GPTKB entity
Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
amphetamine
entactogen recreational drug stimulant |
| gptkbp:ATCCode |
none
|
| gptkbp:CASNumber |
1631-82-7
|
| gptkbp:chemicalFormula |
C12H17NO2
|
| gptkbp:discoveredBy |
gptkb:Alexander_Shulgin
|
| gptkbp:effect |
stimulant
entactogenic empathogenic |
| gptkbp:firstSynthesized |
1912
|
| gptkbp:hasInChIKey |
QZQOTXMEYKFZBV-UHFFFAOYSA-N
|
| gptkbp:hasSMILES |
CCNC(CC1=CC2=C(C=C1)OCO2)C
|
| https://www.w3.org/2000/01/rdf-schema#label |
3,4-methylenedioxy-N-ethylamphetamine
|
| gptkbp:IUPACName |
1-(1,3-benzodioxol-5-yl)-N-ethylpropan-2-amine
|
| gptkbp:legalStatus |
gptkb:Schedule_I_(US)
gptkb:Class_A_(UK) Schedule I (Canada) |
| gptkbp:molecularWeight |
207.27 g/mol
|
| gptkbp:otherName |
gptkb:MDEA
gptkb:Eve |
| gptkbp:PubChem_CID |
19131
18059 2106062 |
| gptkbp:relatedTo |
gptkb:MDA
gptkb:MDMA |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:UNII |
6Z5F8O2E2X
|
| gptkbp:usedFor |
recreational drug
|
| gptkbp:bfsParent |
gptkb:MDEA
|
| gptkbp:bfsLayer |
7
|